Bone Marrow TransplantationTransplantation, AutologousBone MarrowBone NeoplasmsBone Marrow CellsStem Cell TransplantationTransplantation, HomologousBone and BonesGraft vs Host DiseaseBone Marrow PurgingWhole-Body IrradiationHematopoietic Stem CellsHematopoietic Stem Cell TransplantationLeukemiaCombined Modality TherapyCyclophosphamideAnemia, AplasticBone Marrow DiseasesTransplantation ConditioningGraft SurvivalHematopoiesisStem CellsBusulfanLymphoma, Non-HodgkinColony-Forming Units AssayTissue DonorsTransplantation ChimeraBone RemodelingBone Marrow ExaminationMice, Inbred C57BLTreatment OutcomeLeukemia, Myeloid, AcuteBone Marrow NeoplasmsTime FactorsCarmustineCell DifferentiationHistocompatibility TestingRadiation ChimeraRecurrenceRemission InductionHistocompatibilityPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Combined Chemotherapy ProtocolsTransplantation, IsogeneicMelphalanLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone DensityImmunosuppressive AgentsGranulocyte Colony-Stimulating FactorCells, CulturedHematologic NeoplasmsHodgkin DiseaseSurvival AnalysisImmunosuppressionT-LymphocytesFlow CytometryAcute DiseaseKidney TransplantationEtoposideAntigens, CD34Mesenchymal Stem Cell TransplantationCytomegalovirus InfectionsHematologic DiseasesBone ResorptionGraft RejectionCell SeparationHepatic Veno-Occlusive DiseaseRetrospective StudiesMyelodysplastic SyndromesHematopoietic Stem Cell MobilizationLiver TransplantationActuarial AnalysisCytarabineCyclosporineBone RegenerationMultiple MyelomaFollow-Up StudiesLeukocyte CountLymphocyte DepletionGraft vs Host ReactionSurvival RateLymphomaDisease-Free SurvivalBone TransplantationMice, Inbred BALB CGranulocytesHLA AntigensChimeraOsteogenesisAntigens, CDMesenchymal Stromal CellsOpportunistic InfectionsThiotepaLeukocyte TransfusionImmunocompromised HostSpleenCell LineageBone DevelopmentNuclear Family